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Manufacture of lead-containing products has long been associated with various health risks. To get an insight into the 
related genotoxic risks, we conducted a biomonitoring study in 50 exposed workers and 48 matched controls using a 
battery of endpoints that sensitively detect the extent of genome instability in peripheral blood lymphocytes. The levels 
of primary DNA damage were estimated with the alkaline comet assay, while cytogenetic abnormalities were determined 
with the cytokinesis-block micronucleus (CBMN) cytome assay. Additionally, CBMN slides of 20 exposed and 16 control 
participants were subjected to fluorescence in situ hybridisation (FISH), coupled with pancentromeric probes to establish 
the incidence of centromere-positive micronuclei, nuclear buds, and nucleoplasmic bridges. Blood lead levels (B-Pb) 
were measured with atomic absorption spectrometry. To further characterise cumulative effects of occupational exposure, 
we measured erythrocyte protoporphyrin (EP) concentrations and delta-aminolevulinic acid dehydratase (ALAD) activity 
in blood. We also assessed the influence of serum folate (S-folate) and vitamin B12 (S-B12) on genome stability. Compared 
to controls, occupationally exposed workers demonstrated significantly higher B-Pb (298.36±162.07 vs 41.58±23.02), 
MN frequency (18.71±11.06 vs 8.98±7.50), centromere positive MN (C+ MN) (8.15±1.8 vs 3.69±0.47), and centromere 
negative MN (C- MN) (14.55±1.80 vs 4.56±0.89). Exposed women had significantly higher comet tail intensity (TI) and 
length (TL) than control women. Furthermore, workers showed a positive correlation between age and nuclear buds and 
MN, between MN and years of exposure, and between S-B12 levels and TI and ALAD activity, while a negative correlation 
was found between TI and B-Pb. These findings suggest that occupational settings in the manufacture of lead-containing 
products pose significant genotoxic risks, which calls for developing more effective work safety programmes, including 
periodical monitoring of B-Pb and genetic endpoints.
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Lead (Pb) can damage the liver, kidney, brain, and the 
nervous, reproductive, cardiovascular, and immune systems 
(1, 2) by inhibiting the activity of many enzymes and 
contributing to oxidative stress (3, 4). It damages DNA by 
increasing the rate of DNA single- and double-strand breaks 
(5, 6) DNA-protein cross-links (5) and by inducing 
micronuclei (6, 7) and chromosomal aberrations (8). It can 
also enhance the genotoxicity of other DNA damaging 
agents (such as UV light, X-rays, and certain chemicals) 
by interfering with DNA replication fidelity and repair 
(9–11). Literature data about mutagenic, clastogenic, and 
carcinogenic properties of Pb compounds are inconsistent, 
and the International Agency for Research on Cancer 
(IARC) has classified inorganic Pb compounds as possible 
human carcinogens (Group 2B) (12).
Blood lead (B-Pb) level is the most common biological 
marker of recent lead exposure (13) and is largely used in 
industry to monitor Pb exposure of workers and protect 
their health (14). The EU Scientific Committee on 
Occupational Exposure Limits (SCOEL) (15) has 
recommended an occupational exposure limit (OEL) of 
100 µg/m3 (fumes and dust) and a biological limit value 
(BLV) for B-Pb of 300 µg/L (for both men and women). 
Current EU OEL for B-Pb in lead battery plant workers is 
70 µg/mL of blood (16). SCOEL has proposed to lower this 
limit to 30 µg/mL (17).
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However, even concentrations below this limit have 
adverse health effects, including the inhibition of haeme 
synthesis (18), high blood pressure (19, 20), heart disease 
(21), musculoskeletal diseases (22), and gastrointestinal 
symptoms (23). Of the three enzymes lead inhibits in haeme 
biosynthesis, delta-aminolevulinic acid dehydratase 
(ALAD) is affected the most (24). ALAD activity is a 
sensitive indicator of early Pb effects and a biomarker of 
oxidative stress in a lead-exposed haematological system 
(24–26). Another useful marker is erythrocyte protoporphyrin 
(EP), as it can detect mild increases in B-Pb concentration 
under conditions of occupational exposure (27, 28).
Methods for measuring different cytogenetic and 
molecular endpoints (such as cytokinesis-block 
micronucleus assay, analysis of structural chromosome 
aberrations, fluorescence in situ hybridisation, or comet 
assay) have proved themselves useful in the assessment of 
adverse Pb effects on genetic material (29–35).
The aim of this study was to combine biochemical and 
cytogenetic markers of Pb exposure, not only to establish 
exposure to Pb through B-Pb quantification and the above 
mentioned parameters but to evaluate its genotoxic effects 
in occupationally exposed battery and ceramic tile workers. 
To get a more accurate picture of these effects we combined 
the cytokinesis-block micronucleus (CBMN) and the 
alkaline comet assay. In a smaller subgroup we also 
combined CBMN with fluorescence in situ hybridisation 
(FISH) using pancentromeric DNA probes to get a better 
insight into the content of micronuclei (MN), nuclear buds 
(NB), and nucleoplasmic bridges (NPB). Our secondary 
aim was to see how erythrocyte protoporphyrin (EP) 
concentrations, delta-aminolevulinic acid dehydratase 
(ALAD) activity, serum folate and vitamin B12 levels were 
related to genotoxic effects.
SUBJECTS AND METHODS
Study population
Our study included 50 Pb-exposed workers (13 women 
and 33 men) with an average age of 38.4±9.71 years (range: 
18–57 years) who voluntarily participated in the study. They 
spent 10.36±8.94 years (range: 0–34 years) continuously 
working in battery or ceramic tile production (Zagreb and 
Hrvatsko Zagorje region, Croatia).
The control group consisted of 48 healthy voluntary 
blood donors who matched the exposed workers by age, 
gender, and smoking status [18 women and 30 men with 
an average age of 38.65±1.53 years (range: 18–57 years)] 
from the general Croatian population, whose blood samples 
were collected at the Croatian Institute for Transfusion 
Medicine, Zagreb, Croatia. They had no history of 
occupational exposure to Pb or other known genotoxic 
agents nor did they undergo diagnostic or therapeutic 
procedures involving ionising or non-ionising radiation.
A smaller, randomly selected subgroup of 20 Pb-
exposed workers (8 women and 12 men) and 17 controls 
(6 women and 11 men) was also assessed with fluorescence 
in situ hybridisation (FISH).
All the participants signed informed consent before 
entering the study. Information about their health, lifestyle, 
job conditions, smoking status (smoker or never-smoker; 
there were no former smokers in either group), alcohol 
consumption, vitamin supplementation, and X-ray 
examinations was collected through interviews. Those who 
had undergone radiotherapy or chemotherapy or had any 
serious viral infections in the past year were excluded from 
the study.
Blood sampling
Blood samples of exposed workers were collected in 
the morning (following the shift of the day before) under 
sterile conditions by venepuncture in vacutainer tubes (trace 
element K2EDTA 10.8 mg vacutainer) for B-Pb (Becton 
Dickinson and Company, Franklin Lakes, NJ, USA), in clot 
activator tubes for vitamins (Becton Dickinson, Plymouth, 
UK), and in LH 170 IU vacutainer tubes for ALAD, MN, 
and comet assay (Becton Dickinson and Company, Franklin 
Lakes, NJ, USA) at the Mutagenesis Unit of the Institute 
for Medical Research and Occupational Health, Zagreb, 
Croatia. These workers had been working eight-hour shifts 
a day five days a week and usually came for sampling in 
the middle of week.
Control blood samples were collected at the Croatian 
Institute for Transfusion Medicine, Zagreb, Croatia. All 
blood samples were handled in the same manner. After 
collection, they were coded, kept refrigerated, and processed 
as quickly as possible (usually within 2 h of sampling). 
Further laboratory manipulations with blood samples and 
all investigations were carried out in accordance with a high 
standard of ethics. All research procedures complied with 
the Declaration of Helsinki and the Convention for the 
Protection of Human Rights and Dignity of the Human 
Being with regard to the Application of Biology and 
Medicine. The study was approved by the Ethics Committee 
of the Institute for Medical Research and Occupational 
Health, Zagreb, Croatia (28 Feb 2006). One operator scored 
comet assay slides, one MN assay slides, and one FISH-MN 
assay slides.
CBMN assay and MN-FISH
The CBMN assay detects DNA damage and 
abnormalities in human peripheral blood lymphocytes such 
as chromosomal breakage and loss, nucleoplasmic bridges, 
nuclear buds, apoptosis, necrosis, and inhibition of cell 
division (36). Fluorescence in situ hybridisation (FISH) has 
made it possible to reveal the origin of observed micronuclei. 
An increase in the ratio of centromere-positive micronuclei 
indicates more pronounced aneugenic activity of the agent 
of concern (37).
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0.5 % low melting point (LMP) agarose (Sigma) pipetted 
onto fully frosted slides (Surghipath, Richmond, IL, USA) 
precoated with 300 µL of 0.6 % NMA (normal melting 
agarose). After gelation on ice, 0.5 % LMP was used as a 
final protective layer. Slides were then placed in cold lysis 
solution [2.5 mol/L NaCl, 100 mmol/L Na2EDTA, 10 mmol/ 
l Tris, pH 10, and 1 % sodium lauroyl sarcosinate to which 
10 % of dimethylsulphoxide (DMSO) and 1 % Triton X-100 
were added immediately before use] overnight. After lysis, 
slides were placed in electrophoresis solution (300 mmol/L 
NaOH and 1 mmol/L Na2EDTA, pH 13) for 20 min to allow 
DNA to unwind. Electrophoresis took place in a horizontal 
electrophoresis power tank (Life Technologies, Gaithersburg, 
MD, USA) with the same fresh buffer by applying an 
electric current of 300 mA at 25 V for 20 min. Finally, slides 
were washed with neutralisation buffer (0.4 mol/L Tris, pH 
7.5) three times for 5 min and stained with ethidium bromide 
(20 µg/ mL, Sigma). All steps of the comet assay preceding 
electrophoresis were performed on ice to prevent repair and 
effects of metabolic processes. To avoid possible variation 
during electrophoresis, two parallel replicate slides per 
sample were prepared, and each replicate was processed in 
a different electrophoretic run. Image analysis was 
performed using an automatic digital analysis system 
(Comet Assay II, Perceptive Instruments Ltd., Suffolk, 
Halstead, UK) fitted with a Leitz Orthoplan fluorescence 
microscope equipped with an excitation filter of 515–
560 nm.
A total of 200 randomly selected comets were measured 
per person (i.e. 100 comets per replicate slide). The two 
main comet parameters – tail length (TL) (expressed in 
micrometres) and tail intensity (TI) (i. e. DNA % in tail) 
– were used as indicators of primary DNA damage.
Biomarkers of Pb exposure
B-Pb levels were determined with electrothermal atomic 
absorption spectrometry (AAS) with the Zeeman-effect 
background correction (46). The accuracy of the 
measurements was controlled daily by analysing three 
reference blood samples with certified B-Pb values (BCR 
No. 194–196, Community Bureau of Reference, Commission 
of the European Communities, Brussels, Belgium) and 
through laboratory’s regular participation in the National 
External Quality Assessment Scheme (NEQAS, 
Birmingham, UK).
EP concentration was measured by a spectrofluorometric 
method described elsewhere (27) and the accuracy 
controlled through regular participation in an erythrocyte 
protoporphyrin proficiency-testing program (Pennsylvania 
Department of Health, Bureau of Laboratories, Lionville, 
PA, USA).
Erythrocyte ALAD activity was measured using a 
standardised method described elsewhere (47). The 
principle of the method is based on the porphobilinogen 
(PGB) formation in excess of delta-aminolevulinic acid 
On the same day when samples were collected, standard 
culturing procedures were employed with small 
modifications as first described by Fenech and Morley (38) 
and modified by Fenech (36).
For cytochalasin B blocked micronucleus assay, each 
0.8 mL whole blood sample was cultured in 8 mL of RPMI 
1640 medium (Sigma-Aldrich, St. Louis, MD, USA) 
supplemented with 20 % foetal bovine serum (Sigma), 
0.2 mL of PHA-M (Biological Industries, Beit-Haemek, 
Israel), and penicillin and streptomycin (Sigma). 
Cytochalasin B (Sigma) (in the final concentration of 6 μg/
mL) was added at hour 44 to stop cytokinesis, and culturing 
continued until hour 72. Each culture was centrifuged at 
800 rpm for 8 min, and the obtained pellet mixed with cold 
110 mmol/L KCl, left at room temperature for 15 min, and 
fixed with freshly prepared solution of methanol:acetic acid 
(3:1) with three drops of formaldehyde (formaldehyde was 
used only in the first fixative). A total of 1000 binucleated 
cells per sample with a well-preserved cytoplasm was 
analysed for MN, NB, and NPB frequency according to the 
criteria proposed by Fenech et al. (39). All samples were 
coded, so the operator was unaware of the group to which 
the sample belonged. Cell proliferation was expressed as 
nuclear division index (NDI) as follows:
NDI=(M1+2M2+3M3+4M4)/N
where M1, M2, M3,
 and M4 indicate the number of cells 
with one, two, three, and four nuclei, and N the total number 
of cells analysed (1000 per sample) (40).
To detect centromeres in MN, FISH was performed 
using commercial all human centromere satellite, direct 
labelled probes (Qbiogene, Inc., Irvine, CA, USA) ) 
according to manufacturer’s instructions. The FISH assay 
included a smaller randomly selected group of 20 Pb-
exposed workers (8 women and 12 men) and 17 controls 
(6 women and 11 men). Probes were labelled with a red 
fluorophore (Texas red spectrum), and slides stained with 
a solution of 4,6-diamidino-2-phenylindole (DAPI) 
prepared with antifade solution (Qbiogene). Slides were 
then analysed with an Olympus AX-70 epifluorescence 
microscope at 1000x magnification (Olympus Optical, 
London, UK) to establish the incidence of centromere-
positive MNs (C+ MN), centromere positive NBs (C+ NBs), 
and NPBs (C+ NPBs). At least 1000 binuclear cells per 
subject were analysed. A C+ MN represents aneugenic 
events, and a centromere-negative MN (C- MN) represents 
clastogenic events (41).
Alkaline comet assay
The alkaline comet assay is a rapid, sensitive technique 
for measuring DNA strand breaks, alkali-labile sites, and 
cross links with DNA in individual cells (42–44). It was 
performed according to the method described by Singh et 
al. (45) with minor modifications. Cells were suspended in 
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(ALA). ALAD activity corresponds to the quantity of PGB 
produced during the incubation of the enzyme at 37 °C in 
excess of ALA in the phosphate buffer (pH=6.4). PGB was 
measured with a spectrophotometer (Cary® 50 UV-Vis, 
Varian, Inc., Palo Alto, CA, USA) at 555 nm after addition 
of a modified Ehrlich’s reagent. The results were expressed 
as units per litre of erythrocytes (U/L ercs). All samples 
were measured in duplicate, and the coefficients of variation 
(CVs) were less than 5 %.
According to Croatian legislation (48), current 
biological limit values for Pb exposure are as follows: 
B-Pb<400 µg/L for male and <300 µg/L for female workers; 
ALAD>15 U/L ercs; and EP<2.67 µmol/L ercs.
Serum folate and vitamin B12 concentrations
Folate, also known as vitamin B9, plays an important 
role in DNA and RNA synthesis (49), production of red 
blood cells, maintenance of the nervous system (50), amino 
acid metabolism (51), and in preserving health by reducing 
plasma homocysteine levels (52–55). Beetstra et al. (56) 
found that folate deficiency increases chromosome 
instability.
Vitamin B12 or cyanocobalamin is an important co-factor 
in folate metabolism (57). It is essential for normal DNA 
synthesis, especially in erythrocyte development.
Serum (S-) folate and B12 were quantified using the 
electrochemiluminescence immunoassay (ECLIA) in a 
closed analysis system Elecsys 2010 (Roche Diagnostics 
Elecsys 2010 Immunoassay System, Mannheim, Germany) 
following the manufacturer’s instructions. All analyses were 
performed in Clinical Hospital “Sestre milosrdnice”, 
Laboratory for Clinical Chemistry, Zagreb, Croatia. 
Reference ranges for the Croatian population are 211–
911 ng/L and 3.1–17.5 µg/L for S-B12 and S-folate, 
respectively.
Statistical analysis
As the distribution of results was not normal, the 
differences between the two groups were tested with the 
non-parametric Mann-Whitney U test. Spearman’s rank-
order correlation test was used to evaluate the influence of 
age, years of exposure, smoking, B-Pb, S-B12, S-folate, and 
ALAD and EP activity on the CBMN and alkaline comet 
assay parameters. Confounding factors were identified with 
multiple regression analysis. Differences with p<0.05 were 
considered statistically significant. Separate analyses were 
used for the exposed and control group. All statistics was 
run on the Statistica 13.2 package (Dell Inc., Round Rock, 
TX, USA).
RESULTS
Table 1 summarises the general characteristics of the 
study groups including their age, gender, work experience 
(years), smoking habit, B-Pb levels, serum vitamin B12 and 
folate concentrations, ALAD activity, and EP concentrations. 
Table 2 breaks down these findings by gender and smoking 
status.
B-Pb levels in the exposed workers were at least seven 
times higher than in controls (298.36±162.07 µg/L vs 
control 41.58±23.02 µg/L) (Table 1). They were also 
significantly higher (p<0.05) in exposed men than exposed 
women (p<0.05), in exposed women than control women 
(p<0.05), in exposed smokers than exposed non-smokers 
(p<0.05) and control smokers (p<0.05), and in exposed 
non-smokers than control non-smokers (p<0.05) (Table 2).
Mean ALAD activity in peripheral blood lymphocytes 
in controls was at least twice as high as in the exposed group 
(Table 1). It was also significantly higher (p<0.05) in the 
exposed women than exposed men, in control women than 
the exposed ones, in control men than those exposed, in 
exposed non-smokers than smokers, in control smokers 
than exposed smokers, and in control non-smokers than the 
exposed ones (Table 2).
EP concentrations also significantly differed between 
the groups (Table 1) and respective subgroups (Table 2).
As for S-B12 concentrations, the only significant 
difference between the subgroups was that they were 
significantly higher in control than exposed women (Table 
2).
The same was observed for S-folate concentrations, but 
we also noticed significantly higher means in exposed non-
smokers than smokers. Significantly higher levels were also 
observed in control vs exposed subgroups (Table 2).
Table 1 General characteristics of lead-exposed workers and controls
Parameters (mean ± SE) Exposed group (N=50) Control group (N=48)
Age (years) 38.34±9.71 38.65±1.53
Years of exposure 10.36±8.94 0
B-PB (µg/L) 298.36±162.07 41.58±23.02
ALAD (U/L ercs) 23.32±15.87 56.32±9.92
EP (µmol/L ercs) 3.05±3.43 0.98±0.27
S-B12 (ng/L) 446.25±137.98 473.08±166.99
S-folate (ng/L) 5.83±2.31 7.69±3.70
Significant differences (p<0.05, non-parametric Mann Whitney U test) are in bold typeface. ALAD – delta-aminolevulinic acid 
dehydratase activity; B-Pb – blood lead concentrations; EP – blood erythrocyte protoporphyrin concentrations; ercs – erythrocytes; 
S-B12 – serum vitamin B12 concentrations; SE – standard error; S-folate – serum folate concentrations
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Table 3 shows the results of the CBMN and comet assay. 
Mean MN frequency in peripheral blood lymphocytes of 
the exposed workers was at least twice as high as in controls 
(18.71±11.06 vs 8.98±7.50; p<0.05). Significantly higher 
MN frequency was also observed in the exposed vs control 
women and men, exposed smokers vs non-smokers, 
exposed vs control smokers, and exposed vs control non-
smokers.
Controls and exposed workers did not differ significantly 
in NB count, regardless of gender or smoking status.
Significant difference in NPB count was observed only 
at the study group level (p<0.05).
Considering NDI, a significant (p<0.05) difference was 
observed between exposed and control men, exposed 
smokers and non-smokers, exposed and control smokers, 
and between exposed and control non-smokers.
Spearman’s correlation test showed a significant 
contribution of age to MN frequency in both controls 
(r=0.49, p<0.05) and exposed workers (r=0.36, p<0.05), 
whose years of exposure also contributed to it (r=0.31 
p<0.05).
B-Pb level negatively correlated with NDI in the control 
group (r=-0.51, p<0.05), while ALAD activity correlated 
with NPB count in the exposed group (r=0.31, p<0.05).
The control group had a positive correlation between 
S-B12 and the NPB/MN ratio (r=0.30 p<0.05) and negative 
correlation between S-B12 and MN and TI (r=-0.29, p<0.05; 
r=-0.47, p<0.05, respectively). S-folate negatively 
correlated only with NBs in the exposed group (r=-0.31, 
p<0.05).
The results of the FISH assay are presented in Tables 4 
and 5. The MNtotal, C+ MN, C- MN, total NPB, and C- NPB 
frequencies were significantly higher in the exposed group 
than control. The two groups, however, showed no 
significant differences in the frequency of total NB, C+ NB, 
C- NB, and C+ NPB.
As expected, MNtotal frequencies were significantly 
higher in control smokers than non-smokers. MNtotal and 
C- MN frequencies were significantly higher in the exposed 
vs control smokers. The exposed non-smokers had all three 
FISH parameters (MNtotal, C+ MN, C- MN) significantly 
higher than controls.
Exposed men had significantly higher MNtotal and 
C- MN frequencies than control men, whereas exposed 
women had significantly higher all three parameters (MNtotal, 
C+ MN, and C- MN) than control women.
There were no correlations in the FISH-tested control 
subgroup, but in exposed men age negatively correlated 
with total NB (r=-0.66, p<0.05).
As for the comet assay results, the only significant 
difference was in the tail length between the exposed and 
control women. Male gender positively correlated with tail 
length in the control group (r=0.42; p=0.00382). B-Pb level 
negatively correlated with TI in the exposed group (r=-0.30, 



























































































































































































































































































































































































































































































































































































































































































































































the exposed group (r=0.31, p<0.05 and r=0.41, p<0.05, 
respectively).
EP concentration negatively correlated with TL and TI 
in the exposed group (r=-0.28, p<0.05 and r=-0.39, p<0.05, 
respectively).
S-B12 levels positively correlated with TL and TI in the 
exposed group (r=0.48, p<0.05 and r=0.32 p<0.05, 
respectively).
Multiple regression analysis showed statistically 
significant interdependence between MN frequency and 
years of exposure (R2=0.587, p=0.035) and NDI (R2=0.587, 
p=0.0006) as well as between NDI and B-Pb level, and EP 
and S-folate, all in exposed subjects (R2=0.841, p=0.0121; 
R2=0.711, p=0.0083; R2=0.543, p=0.000001, respectively).
In the control group age significantly contributed to MN 
frequency (R2=0.269, p=0.0076), while ALAD activity 
significantly contributed to the occurrence of NB (R2=0.713, 
p=0.0069) and NPB (R2=0.713, p=0.0371) counts and NDI 
(R2=0.713, p=0.0434).
DISCUSSION
In this study we evaluated the influence of age, years 
of exposure, smoking status, B-Pb, S-B12, S-folate, and 
ALAD and EP activity on the occurrence of aberrant 
chromatin structures (MN, NPB, NB) and the level of 
primary DNA damage in Pb-exposed workers vs controls.
Over the last two decades, many authors have used B-Pb 
as the biomarker of lead exposure when reporting about its 
genotoxic effects. Vaglenov et al. (11) thus reported higher 
frequency of binucleated cells with MNi in peripheral blood 
of 103 lead-exposed workers and 78 matched controls and 
concluded that B-Pb levels higher than 1.2 µmol/L may 
increase the risk of genetic damage. Relying on the results 
of the MN assay combined with FISH with pancentromeric 
probes, sister chromatid exchanges (SCEs), and the comet 
assay Palus et al. (41) suggested that exposure to Pb and 
Cd in battery plant workers may have both clastogenic and 
aneugenic effects. Minozzo et al. (58) also reported 
significantly higher B-Pb levels and MN frequency in the 
lymphocytes of workers recycling car batteries and 
significantly higher NDI values in controls. These results 
suggest a possible effect of Pb on nuclear proliferation. 
However, they found no significant differences in MN 
frequency between smoking and non-smoking workers. 
Similarly, Danadevi et al. (59) reported significantly higher 
Pb levels and DNA damage in workers on secondary lead 
recovery compared to controls and little difference in DNA 
damage between smoking and non-smoking workers.
As expected, Pb levels and years of exposure 
significantly correlated with DNA damage. In a study of 
battery plant workers, Fracasso et al. (60) pointed to a 
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Table 3 Micronucleus assay and alkaline comet assay endpoints in lead-exposed workers and controls by gender and smoking
Parameters 
(mean±SE) Total MNi NDI TL TI
Total 
NBs Total NPBs NPB/MN ratio
Exposed 
(N=50) 18.71±11.06
a 2.17±0.23a 16.15±5.33 2.64±3.22 3.65±5.91 2.02±2.47a 0.12±0.02
Controls 
(N=48) 8.98±7.50 2.13±0.25 14.27±1.23 1.61±0.74 2.29±2.34 1.14±1.53 0.26±0.08
Control W 
(N=18) 8.11±1.72 2.22±0.06 13.67±0.21
b 1.34±0.16b
Control M 
(N=30) 9.5±1.41 2.07±0.05 14.67±0.25 1.79±0.14
Exposed W 
(N=17) 20.06±2.09
d 2.16±0.07 16.19±1.28d 3.04±0.92d
Exposed M 
(N=33) 18.4±2.23











Significant differences (p<0.05, non-parametric Mann Whitney U test) are in bold typeface. 1000 binuclear cells per subject were 
analysed. a – controls vs exposed workers; b – control women vs control men; d – control women vs exposed women; e – exposed 
men vs control men; f – exposed smokers vs exposed non-smokers; g – exposed smokers vs control smokers; h – exposed non-smokers 
vs control non-smokers. M – men; MNi – micronuclei; NBs – nuclear buds; NDI – nuclear division index; NPBs – nucleoplasmic 
bridges; NS – non-smokers; S – smokers; SE – standard error; TI – tail intensity; TL – tail length; W – women
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correlation between increased DNA breaks and oxidative 
stress (increased reactive oxygen species production and 
low glutathione levels).
In a three-year biomonitoring study Valverde et al. (30) 
found that recycling battery workers exceeded allowed B-Pb 
of 10 µg/dL nearly five times, had significant inhibition of 
ALAD, and about 47 % higher basal DNA damage than 
controls. Their DNA repair rate was about 28% slower than 
that of controls. Similarly, Olewinska et al. (61) reported 
significantly higher tail DNA % and TL in lead-exposed 
metal workers than controls and a positive correlation 
between years of exposure and tail DNA %, TL, and tail 
moment. Balasubramanian et al. (62), in turn, reported that 
years of exposure to Pb (in organic lead workers) was the 
only significant feature that resulted in increased genotoxic 
potential.
As for gender differences, we found significantly higher 
B-Pb in men than women of either groups (control women 
had ~40 % lower levels than control men, and exposed 
women had ~33 % lower levels than exposed men). 
Similarly, Theppeang et al. (63) observed 41 % lower 
median B-Pb in women than men aged over 60 (p<0.01). 
Milman et al. (64) reported similar findings and explained 
them with the higher content of haemoglobin in male blood.
Literature data show that smoking is significantly 
related to B-Pb, regardless of gender (65–67), which was 
confirmed by our findings.
ALAD activity and EP concentration reflect cumulative 
long-term Pb-exposure, which is in agreement with the 
results of our and several other studies (14, 68). In addition 
to the negative correlation between B-Pb and ALAD 
activity, Stoleski et al. (69) also reported a positive 
correlation of B-Pb levels with age and years of exposure. 
Huang et al. (70), however, observed no significant effect 
of age and smoking on ALAD activity in lead workers. In 
1973, Piomelli (71) found that EP concentration increases 
exponentially with linear increase in B-Pb levels. A few 
years later, Tomokuni and Ogata (72) confirmed these 
findings in Pb-exposed workers.
As for the protective effects of serum folate and vitamin 
B12, Fenech and Rinaldi (73) reported no significant 
correlation between S-folate and MN frequency in healthy 
men but also reported a significant negative correlation 
between MN frequency and B12 levels. Büyükşekerci et al. 
(74), in turn, showed that B-Pb negatively correlated with 
S-folate levels (r=-0.105, p=0.001) but did not significantly 
correlate with S-B12 (r=-0.061, p=0.062). Lee et al. (75) 
showed on a US general population sample that Pb can 
biologically interact with folate and vitamin B12. In our 
study the only significant differences we found for S-B12 
were those between control and exposed women (who had 
lower S-B12). We did not observe any significant correlation 
between B12 or S-folate and MN frequency in any of the 
groups (Table 1).
The CBMN assay is a well-established method for 
biomonitoring chromosome damage in human populations 
occupationally exposed to different chemical agents. 
Several recent studies (11, 58, 69, 76) observed significantly 
higher MN frequency in lead-exposed workers than 
controls. Some evaluated the influence of smoking on MN 
frequency in population not occupationally exposed to Pb 
and came up with inconsistent findings, ranging from 







Age (years) 39.6±2.05 40.31±1.59
Gender 8 women 12 men
5 women 
11 men
Smoking 12 smokers 8 non-smokers
10 smokers 
6 non-smokers
Time of exposure (years) 11.66±1.91 0
MNtotal 22.70±2.27 8.25±0.84
C+ MNtotal 8.15±1.80 3.69±0.47
C- MNtotal 14.55±1.80 4.56±0.89
NBtotal 2.75±0.53 4.18±1.01
C+ NBtotal 0.35±0.21 0.75±0.28
C- NBtotal 2.40±0.41 3.43±0.74
NPBtotal 1.80±0.53 0.38±0.15
C+ NPBtotal 0.05±0.05 0
C- NPBtotal 1.75±0.54 0.38±0.15
Significant differences (p<0.05, non-parametric Mann Whitney U test) are in bold typeface. 1000 binuclear cells per subject were 
analysed. C + MN – MN with centromeric signal; C- MN – MN without centromeric signal; C+ NB – NB with centromeric signal; 
C- NB – NB without centromeric signal; C+ NPB– NPB with centromeric signal; C- NPB – NPB without centromeric signal; MN – 
micronucleus; NBs – nuclear buds; NPBs – nucleoplasmic bridges; SE – standard error
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increased in smokers (77–80) over no effect (81) to lower 
MN frequency than in non-smokers (82).
Several studies have shown that women have higher 
MN frequencies than men (83–88), possibly due to much 
higher X chromosome micronucleation (89–91) and higher 
X-chromosome loss in women with age (92, 93). In our 
study MN frequency was only higher in the exposed women 
than men (Table 5). Smoking positively affected MN 
formation only in the exposed group (Table 3).
We found no significant difference in NB formation 
between the exposed workers and controls (Table 3). This 
could be expected, considering how NBs as indicators of 
genetic instability are formed (94–96). They are the 
consequence of elimination of amplified genes and 
unresolved DNA repair complexes (94). Inorganic lead did 
not activate any detoxification pathway or induce an over-
expression of genes and consequently their copy number. 
Since the primary DNA damage (TL and TI measured by 
the alkaline comet assay) in exposed workers was not 
significantly higher than in controls (Table 3), the small 
increase observed in NB frequency was not a consequence 
of DNA repair (10, 60). Micronucleus assay detects 
permanent DNA damage, and elevated NB frequency can 
sometimes be the result of a later fusion of formed MN 
within the nucleus. Such conclusion of NB origin is 
supported by our centromere signal analysis in lead-exposed 
workers, as most NBs and MNs were centromere-negative 
(Table 4). This is in line with other studies which 
demonstrated that DNA fragments in the shape of MNi or 
NBs may indicate their common origin (36).
For NPBs we observed significantly higher frequencies 
in the exposed group than controls (Table 2). So far, Pb 
exposure has not been reported to induce significant 
formation of dicentric or ring chromosomes that form 
nucleoplasmic bridges following karyokinesis. We can only 
speculate that the observed NPB formation was mediated 
by telomere fusion due to premature telomere shortening 
as the effect of chronic genome burdening (36). However, 
this theory still remains to be confirmed.
We also calculated the NPB/MN ratio, which may 
provide a fingerprint of specific genotoxic exposure (98). 
It was 0.12±0.02 (median: 0.08) in the exposed group and 
0.26±0.08 (median: 0.11) in the control group. To the best 
of our knowledge, no similar data exist for lead-exposed 
workers but only for people exposed to ionising radiation 
and pesticides as in Thomas et al. (97), who associated 
NPB/MN ratio close to zero with exposure to a strong 
aneugenic agent such as spindle poison and much higher 
ratio (0.77) with exposure to a strong clastogenic agent such 
as ionising radiation. In a study by Želježić et al. (98) that 
evaluated genotoxic effects of acute carbofurane poisoning 
in men, the NPB/MN ratio was 0.19, and the authors 
concluded that carbofuran acted mostly as an aneugen.
Exposure to lead in this study did not affect mitotic 
activity, as both groups had similar NDI (NDIexp=2.17 vs 
NDIcont=2.13), which is in line with the report by Palus et 
al. (41). Minozzo et al. (58), in contrast, found significantly 
higher NDI in battery recycling workers than controls and 
other studies (99–101) showed increased mitotic activity 
in lead exposure.
The correlation analysis of all 50 exposed subjects in 
our study showed that years of exposure and age correlated 
with MN frequency in the exposed workers. That group 
also revealed negative correlation between B-Pb and TI, 
ALAD correlation with NPBs and both TL and TI, S-B12 
correlation with TL and TI, and negative correlation 
between S-folate and NBs. In controls, age positively 
correlated with MN frequency and NDI, and B-Pb 
correlated with NDI. Fenech and Rinaldi (73) reported a 
similar correlation between age and MN frequency, as did 
many other authors (75, 85, 87–88, 102–104).
Popović et al. (67) showed that age positively correlated 
with B-Pb only in control women. Our earlier study (104) 
in pottery glaze workers showed significant associations of 
years of exposure and gender with EP and S-folate. NBs 
correlated with age, smoking, ALAD, and EP. NPBs 
significantly correlated with exposure, years of exposure, 
smoking, B-Pb, ALAD, and EP (104).
Exposed subjects in our study showed a significant 
interdependence between MN and NDI with years of 
exposure. The same was observed for associations between 
NDI and B-Pb level, and EP and S-folate in the exposed 
group. In the control group, age significantly influenced 
MN frequency, and ALAD activity significantly affected 
occurrence of NBs, NPBs, and NDI.
We also observed a significantly higher frequency of 
C+ MN and C- MN in the exposed workers than controls. 
These findings point to both aneugenic and clastogenic 
effects of lead exposure. Studies of hospital and power plant 
workers exposed to ionising radiation (105–108) showed 
that age increased the baseline MN frequencies, which can 
be almost completely attributed to C+ MN. Palus et al. (41) 
reported both clastogenic and aneugenic effects in Pb and 
Cd-exposed battery workers.
It is widely accepted that age and gender are important 
factors influencing MN levels (47, 86, 109–110). The 
frequency of C- MN frequency in our study correlated with 
age, yet Norppa and Falck (111) suggest that age mainly 
increases C+ MN and rarely C- MN frequency. Gorbunova 
and Seluanov (112), in turn, suggest that age-dependent 
C- MN increase could be related diminished DNA repair 
ability with age.
Unlike some studies (7, 59, 60) reporting association 
between primary DNA damage (TL and TI) established by 
the comet assay and Pb-exposure (B-Pb levels) in lead 
workers, we found no such correlation. The only (negative) 
correlation we found was the one between EP levels and 
both TL and TI in the lead-exposed group. These findings 
are in agreement with Garcia-Leston et al. (113, 114) who 
confirmed that occupational exposure was related to higher 
B-Pb but observed no increase in comet assay parameters 
in the exposed individuals.
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However, in our earlier studies (104, 115) we found a 
significant association between primary DNA damage (TI) 
detected by the comet assay and years of exposure.
Age and gender generally represent major confounding 
factors that may affect DNA damage. Previous studies 
(116–118) reported conflicting results regarding the 
influence of gender between healthy and exposed 
populations. Some comet assay studies found a positive 
association between age and DNA damage (119, 120). In 
our study we found higher TL values in control women than 
control men. Control men, in turn, had higher TI values. In 
contrast, Bajpayee et al. (117) (in a healthy Indian 
population) and Hofer et al. (121) (in young healthy 
individuals) reported lower DNA damage in healthy women 
than men. However, it is difficult to compare their findings 
with ours, because our controls were older and had different 
living and eating habits. Even so, these differences could 
partly be explained by oestrogen binding to its receptors 
and promoting higher expression of genes that encode for 
antioxidant enzymes. As a result, mitochondria in female 
cells produce fewer reactive oxygen species (122 – 124). 
In their biomonitoring studies, however, Dušinska et al. ( 
125, 126) did not find any differences in primary DNA 
damage between men and women in control groups. Moller 
(120) also found no correlation between primary DNA 
damage and gender or smoking, but did find a positive 
correlation between DNA damage and age.
To conclude, our study has confirmed earlier reports 
that occupational Pb exposure increases DNA damage. As 
expected, MN frequency as an index of genetic stability 
was affected by age and years of exposure in the exposed 
group and only by age in the control group. MN-FISH 
revealed that the adverse effects in Pb-exposed workers are 
both aneugenic and clastogenic.
These findings once again call for improving safety 
programmes for Pb-exposed workers and for periodical 
monitoring of genetic endpoints in addition to B-Pb level 
monitoring.
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Rezultati biomonitoringa radnika profesionalno izloženih olovu u industriji izrade baterija i keramičkih pločica 
dobiveni primjenom biokemijskih markera, alkalnoga komet-testa i mikronukleus-testa u kombinaciji s 
fluorescencijskom in situ hibridizacijom
Profesionalna izloženost u industriji olova štetno utječe na zdravlje radnika. Ovo je istraživanje provedeno na 50 radnika 
izloženih olovu te 48 ispitanika kontrolne skupine primjenom testova za procjenu genomske nestabilnosti u limfocitima 
periferne krvi. Razine primarnoga oštećenja DNA procijenjene su alkalnim komet-testom, a citogenetičke abnormalnosti 
utvrđene su citohalazin blokiranim mikronukleus-testom (CBMN). Na podskupini od 20 izloženih i 16 kontrolnih ispitanika 
dodatno je proveden mikronukleus-test u kombinaciji s fluorescencijskom in situ hibridizacijom (MN-FISH). Primjenom 
pancentromernih sonda istražili smo učestalost mikronukleusa pozitivnih na centromere, nuklearnih pupova i 
nukleoplazmatskih mostova. Razine olova u krvi (B-Pb) izmjerene su atomskom apsorpcijskom spektrometrijom. Kako 
bismo utvrdili kumulativne učinke profesionalne izloženosti, izmjerili smo koncentracije eritrocitnoga protoporfirina (EP) 
i aktivnost dehidrataze delta-aminolevulinske kiseline (ALAD) u krvi. Također smo procijenili utjecaj serumskoga folata 
(S-folata) i vitamina B12 (S-B12) na stabilnost genoma. U usporedbi s podudarnim kontrolama, profesionalno izloženi 
radnici imali su značajno višu razinu B-Pb (298,36±162,07 vs. 41,58±23,02), učestalost MN-a (18,71±11,06 vs. 8,98±7,50), 
mikronukleusa pozitivnih na centromere (C+ MN) (8,15±1,8 vs. 3,69±0,47) i mikronukleusa negativnih na centromere 
(C- MN) (14,55±1,80 vs. 4,56±0,89). Izložene radnice imale su značajno veći intenzitet (TI) i duljinu (TL) repa u komet-
testu od ženskih kontrola. Nadalje, u radnika je utvrđena pozitivna korelacija između učestalosti jezgrinih pupova i MN-a 
s dobi, između MN-a i godina izloženosti te između TI-ja i aktivnosti ALAD-a i razina S-B12. Negativna korelacija utvrđena 
je između TI-ja i B-Pb. Dobiveni rezultati upućuju na to da profesionalna izloženost olovu predstavlja značajan genotoksični 
rizik, što zahtijeva razvoj učinkovitijih programa zaštite na radu, uključujući povremeno praćenje B-Pb i genetičkih 
markera.
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